Marker Therapeutics MRKR

$ 3.0 -5.51%

Quarterly report 2024-Q3
added 11-14-2024

Marker Therapeutics Total Shareholders Equity 2011-2024 | MRKR

Annual Total Shareholders Equity Marker Therapeutics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
19.6 M	44 M	27.3 M	44.1 M	59.3 M	3.66 M	6.18 M	-21.4 M	-1.02 M	-8.77 M	-6.04 M	-3.46 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
59.3 M	-21.4 M	13.6 M

Quarterly Total Shareholders Equity Marker Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
7.45 M	9.7 M	11.8 M	14.1 M	16.7 M	19 M	15.9 M	19.6 M	22.6 M	28 M	35.7 M	44 M	52.3 M	63.2 M	72.5 M	27.3 M	27.3 M	27.3 M	27.3 M	44.1 M	44.1 M	44.1 M	44.1 M	59.3 M	59.3 M	59.3 M	59.3 M	3.66 M	3.66 M	3.66 M	3.66 M	6.18 M	6.18 M	6.18 M	6.18 M	-21.4 M	-21.4 M	-21.4 M	-21.4 M	-1.02 M	-1.02 M	-1.02 M	-1.02 M	-8.77 M	-8.77 M	-8.77 M	-8.77 M	-6.04 M	-6.04 M	-6.04 M	-6.04 M	-3.46 M	-3.46 M	-3.46 M	-3.46 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
72.5 M	-21.4 M	15.1 M